Fasting blood glucose is predictive of hypertension in a general Japanese population

Objective: This study was conducted to identify whether higher fasting blood glucose levels is predictive of hypertension by a large-scale longitudinal design. Methods: We conducted a retrospective 5-year cohort study using the data from 13 201 Japanese individuals who underwent annual medical examinations in 2004 and were reevaluated 5 years later. This study included individuals without diabetes or hypertension between ages 30 and 85 years in 2004. The cumulative incidences of hypertension over 5 years in each 10 mg/dl of fasting blood glucose levels were calculated. Moreover, we examined risk factors and calculated odds ratios (ORs) for developing hypertension after adjustments for age, sex, BMI, smoking and drinking habits, dyslipidemia, chronic kidney disease, serum uric acid, and fasting blood glucose levels by logistic regression analyses. Results: We analyzed 10 157 participants (age: 48.9 ± 10.7 years; 43.4% men) without diabetes or hypertension in 2004. After multiple adjustments, higher baseline blood glucose level is an independent risk for hypertension (OR: 1.176; 95% CI 1.086–1.275), as well as aging, women, higher BMI, drinking habits, and higher serum uric acid. After stratifying by sex, higher baseline blood glucose level is an independent risk for hypertension both in women (OR: 1.295; 95% CI 1.135–1.478) and men (OR: 1.108; 95% CI 1.001–1.227). When we conducted the same analysis using glycated hemoglobin instead of blood glucose, glycated hemoglobin was not a risk for hypertension. Conclusion: Higher fasting blood glucose is an independent risk for developing hypertension. Further studies are needed to determine if treatment for elevated blood glucose can prevent developing hypertension.

[1]  M. Lanaspa,et al.  Elevated Serum Uric Acid Level Predicts Rapid Decline in Kidney Function , 2017, American Journal of Nephrology.

[2]  Shah Ebrahim,et al.  Fasting Blood Glucose and the Risk of Stroke and Myocardial Infarction , 2009, Circulation.

[3]  P. Nilsson,et al.  The metabolic syndrome: a glance at its history , 2006, Journal of hypertension.

[4]  Taku Inoue,et al.  Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  R. Testa,et al.  Glucose "peak" and glucose "spike": Impact on endothelial function and oxidative stress. , 2008, Diabetes research and clinical practice.

[6]  M. Lanaspa,et al.  Sugar, Uric Acid, and the Etiology of Diabetes and Obesity , 2013, Diabetes.

[7]  L. Ferrucci,et al.  Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[8]  A. Dominiczak,et al.  2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. , 2013, Journal of hypertension.

[9]  David M. Reboussin,et al.  Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines , 2018, Hypertension.

[10]  James O. Hill,et al.  “Metabolically Healthy” Obesity and Hyperuricemia Increase Risk for Hypertension and Diabetes: 5‐year Japanese Cohort Study , 2017, Obesity.

[11]  R. Touyz,et al.  Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies. , 2015, The Canadian journal of cardiology.

[12]  I. Hisatome,et al.  Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hyperuricemia and hypertension , 2014, Hypertension Research.

[13]  M. Lanaspa,et al.  Uric Acid in Hypertension and Renal Disease: The Chicken or the Egg , 2010, Blood Purification.

[14]  Hyon K. Choi,et al.  Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. , 2011, Arthritis and rheumatism.

[15]  B. Howard,et al.  A Longitudinal Study of Hypertension Risk Factors and Their Relation to Cardiovascular Disease: The Strong Heart Study , 2006, Hypertension.

[16]  M. Lanaspa,et al.  Uric acid‐dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  G. Bernini,et al.  The Inter-Relationship between Insulin Resistance and Hypertension , 2012, Drugs.

[18]  G. Filippatos,et al.  Effect of serum insulin on the association between hyperuricemia and incident heart failure. , 2010, The American journal of cardiology.

[19]  H. Black,et al.  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology. , 2015, Circulation.

[20]  S. Kihara,et al.  Other types of primary hyperlipoproteinemia(hyperlipidemia). Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. , 2013, Journal of atherosclerosis and thrombosis.

[21]  D. Adlam,et al.  Distinct and complementary roles for α and β isoenzymes of PKC in mediating vasoconstrictor responses to acutely elevated glucose , 2016, British journal of pharmacology.

[22]  M. Lanaspa,et al.  Uric acid and fructose: potential biological mechanisms. , 2011, Seminars in nephrology.

[23]  S. Kihara,et al.  The elderly. , 2014, Journal of atherosclerosis and thrombosis.

[24]  T. Hayakawa,et al.  Prevalence of hypertension, its awareness and control in adult population in Japan , 2004, Journal of Human Hypertension.

[25]  K. Joshipura,et al.  ASSOCIATION BETWEEN WITHIN-VISIT SYSTOLIC BLOOD PRESSURE VARIABILITY AND DEVELOPMENT OF PRE-DIABETES AND DIABETES AMONG OVERWEIGHT/OBESE INDIVIDUALS , 2017, Journal of Human Hypertension.

[26]  M. Laakso,et al.  High Serum Levels of Advanced Glycation End Products Predict Increased Coronary Heart Disease Mortality in Nondiabetic Women but not in Nondiabetic Men: A Population-Based 18-Year Follow-Up Study , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[27]  D. Maahs,et al.  Fructose and uric acid in diabetic nephropathy , 2015, Diabetologia.

[28]  M. Lanaspa,et al.  Uric Acid Is a Strong Risk Marker for Developing Hypertension From Prehypertension: A 5-Year Japanese Cohort Study , 2018, Hypertension.

[29]  M. Lanaspa,et al.  Asymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases: Five-Year Japanese Cohort Study , 2017, Hypertension.

[30]  J. Meigs,et al.  Hypertension and Diabetes Mellitus: Coprediction and Time Trajectories , 2018, Hypertension.

[31]  C. Borghi,et al.  Serum Uric Acid and Cardiometabolic Disease: Another Brick in the Wall? , 2017, Hypertension.

[32]  J. Shaw,et al.  International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.

[33]  Yutaka Imai,et al.  The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014) , 2014, Hypertension Research.

[34]  Yosikazu Nakamura,et al.  Low frequency of toothbrushing practices is an independent risk factor for diabetes mellitus in male and dyslipidemia in female: A large-scale, 5-year cohort study in Japan. , 2017, Journal of cardiology.

[35]  Maja O’Connor LONGITUDINAL STUDY , 2013 .

[36]  M. Lanaspa,et al.  Uric acid in metabolic syndrome: From an innocent bystander to a central player. , 2016, European journal of internal medicine.

[37]  M. Litwin,et al.  Guidelines for the Management of Hypertension , 2015 .

[38]  P. Chou,et al.  Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. , 2000, The Journal of rheumatology.

[39]  M. Kuwabara Hyperuricemia, Cardiovascular Disease, and Hypertension , 2016, Pulse.

[40]  B. Djindjic,et al.  The contributions of fasting and postprandial blood glucose increments to oxidative stress and inflammation in dyslipidemic type 2 diabetic patients with stable ischemic heart disease. , 2017, International journal of cardiology.

[41]  B. Balkau,et al.  Euglycemic Clamp Insulin Sensitivity and Longitudinal Systolic Blood Pressure: Role of Sex , 2013, Hypertension.

[42]  M. Lanaspa,et al.  Increased Serum Sodium and Serum Osmolarity Are Independent Risk Factors for Developing Chronic Kidney Disease; 5 Year Cohort Study , 2017, PloS one.

[43]  S. Nitter‐Hauge,et al.  Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. , 1999, Diabetes care.

[44]  P. Zimmet,et al.  International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.

[45]  Yaqin Yu,et al.  Association of Blood Pressure with Fasting Blood Glucose Levels in Northeast China: A Cross-Sectional Study , 2018, Scientific Reports.

[46]  Tobias Jung,et al.  Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus , 2015, Biomolecules.